UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 136

Sortiert nach

IL-13 Acutely Augments HIV-Specific and Recall Responses from HIV-1-Infected Subjects In Vitro by Modulating Monocytes

Journal of Immunology, 2005-10, Vol.175 (8), p.5532-5540

2005

Volltextzugriff (PDF)

IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression

The Journal of immunology (1950), 1999-06, Vol.162 (12), p.7534-7542

1999

Volltextzugriff (PDF)

IL-13 and IFN-{gamma} Secretion by Activated T Cells in HIV-1 Infection Associated with Viral Suppression and a Lack of Disease Progression

The Journal of immunology (1950), 1999-06, Vol.162 (12), p.7534

1999

Volltextzugriff (PDF)

153: THE HEPATITIS C CARE CASCADE DURING THE DIRECT-ACTING ANTIVIRAL ERA WITHIN A NATIONALLY REPRESENTATIVE UNITED STATES HEALTH CLAIMS DATABASE

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1117-S-1118

2022

Volltextzugriff (PDF)

1603Increased Risk of Hip Fracture Associated with Dually-Treated HIV/Hepatitis B Virus Coinfection

Open forum infectious diseases, 2014-12, Vol.1 (suppl_1), p.S427-S427

2014

Volltextzugriff (PDF)

645Structural Bone Deficits in HIV/HCV, HCV-Monoinfected, and HIV-Monoinfected Women

Open forum infectious diseases, 2014-12, Vol.1 (suppl_1), p.S33-S33

2014

Volltextzugriff (PDF)

Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study

Open forum infectious diseases, 2018-06, Vol.5 (6), p.ofy076

2018

Volltextzugriff (PDF)

Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy

Clinical infectious diseases, 2015-12, Vol.61 (12), p.1825-1830

2015

Volltextzugriff (PDF)

Adherence to Hepatitis C Virus Therapy and Early Virologic Outcomes

Clinical infectious diseases, 2009-01, Vol.48 (2), p.186-193

2009

Volltextzugriff (PDF)

Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV

AIDS (London), 2018-08, Vol.32 (13), p.1763-1772

2018

Volltextzugriff (PDF)

Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV

AIDS (London), 2018-08, Vol.32 (13), p.1763-1772

2018

Volltextzugriff (PDF)

Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV

AIDS (London), 2018-06

2018

Volltextzugriff (PDF)

Anemia during treatment of hepatitis C in HIV-infected patients

The AIDS reader, 2004-10, Vol.14 (10), p.555

2004

Volltextzugriff (PDF)

Association of Host Genetic Risk Factors With the Course of Cytomegalovirus Retinitis in Patients Infected With Human Immunodeficiency Virus

American journal of ophthalmology, 2011-06, Vol.151 (6), p.999-1006.e4

2011

Volltextzugriff (PDF)

Baseline Viral Load and Immune Activation Determine the Extent of Reconstitution of Innate Immune Effectors in HIV-1-Infected Subjects Undergoing Antiretroviral Treatment

Journal of Immunology, 2007-08, Vol.179 (4), p.2642-2650

2007

Volltextzugriff (PDF)

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.597-605

2013

Volltextzugriff (PDF)

Book reviews

Journal of General Internal Medicine, 1993, Vol.8 (9), p.523-524

1993

Volltextzugriff (PDF)

Circulating Monocytes in HIV-1-Infected Viremic Subjects Exhibit an Antiapoptosis Gene Signature and Virus- and Host-Mediated Apoptosis Resistance

The Journal of immunology (1950), 2009-04, Vol.182 (7), p.4459-4470

2009

Volltextzugriff (PDF)

Circulating Monocytes in HIV-1-Infected Viremic Subjects Exhibit an Antiapoptosis Gene Signature and Virus- and Host-Mediated Apoptosis Resistance1

The Journal of immunology (1950), 2009-04, Vol.182 (7), p.4459-4470

2009

Volltextzugriff (PDF)

Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruption

AIDS (London), 2021-10, Vol.35 (12), p.2051-2054

2021

Volltextzugriff (PDF)

The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci

Chemotherapy (Basel), 1996-07, Vol.42 (4), p.235

1996

Volltextzugriff (PDF)

A comparison of Streptococcus pyogenes (group A streptococcal) bacteremia at an urban and a suburban hospital. The importance of intravenous drug use

Archives of internal medicine (1960), 1993-12, Vol.153 (23), p.2679

1993

Volltextzugriff (PDF)

Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people

BMC gastroenterology, 2019-04, Vol.19 (1), p.52-52, Article 52

2019

Volltextzugriff (PDF)

Comparison of Treatment Regimens for Cytomegalovirus Retinitis in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy

Ophthalmology (Rochester, Minn.), 2013-06, Vol.120 (6), p.1262-1270

2013

Volltextzugriff (PDF)

Correction for Patro et al., Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-Related ISG/Bcl2 Family Gene Expression in Chronically HIV-1-Infected Subjects

Journal of virology, 2015-07, Vol.89 (13), p.6970-6970

2015

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(135)
Reviews
(1)

Sprache

Englisch
(136)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IL-13 Acutely Augments HIV-Specific and Recall Responses from HIV-1-Infected Subjects In Vitro by Modulating Monocytes

IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression

IL-13 and IFN-{gamma} Secretion by Activated T Cells in HIV-1 Infection Associated with Viral Suppression and a Lack of Disease Progression

153: THE HEPATITIS C CARE CASCADE DURING THE DIRECT-ACTING ANTIVIRAL ERA WITHIN A NATIONALLY REPRESENTATIVE UNITED STATES HEALTH CLAIMS DATABASE

1603Increased Risk of Hip Fracture Associated with Dually-Treated HIV/Hepatitis B Virus Coinfection

645Structural Bone Deficits in HIV/HCV, HCV-Monoinfected, and HIV-Monoinfected Women

Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study

Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy

Adherence to Hepatitis C Virus Therapy and Early Virologic Outcomes

Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV

Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV

Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV

Anemia during treatment of hepatitis C in HIV-infected patients

Association of Host Genetic Risk Factors With the Course of Cytomegalovirus Retinitis in Patients Infected With Human Immunodeficiency Virus

Baseline Viral Load and Immune Activation Determine the Extent of Reconstitution of Innate Immune Effectors in HIV-1-Infected Subjects Undergoing Antiretroviral Treatment

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

Book reviews

Circulating Monocytes in HIV-1-Infected Viremic Subjects Exhibit an Antiapoptosis Gene Signature and Virus- and Host-Mediated Apoptosis Resistance

Circulating Monocytes in HIV-1-Infected Viremic Subjects Exhibit an Antiapoptosis Gene Signature and Virus- and Host-Mediated Apoptosis Resistance1

Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruption

The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci

A comparison of Streptococcus pyogenes (group A streptococcal) bacteremia at an urban and a suburban hospital. The importance of intravenous drug use

Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people

Comparison of Treatment Regimens for Cytomegalovirus Retinitis in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy

Correction for Patro et al., Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-Related ISG/Bcl2 Family Gene Expression in Chronically HIV-1-Infected Subjects

Suchergebnisse filtern